C07D217/00 - CPC Classification Index

ClassID:

94291 ⎘

C07D217/00 - CPC Classification

Classification description:

Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Sub-classes:

C07D217/02 » with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines 376
C07D217/12 » with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring 57
C07D217/22 » with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring 346

Recent Application in this class:

20230312644

2023-10-05

COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING

20230233551

2023-07-27

COMPOSITIONS AND METHODS FOR TREATMENT

20210363141

2021-11-25

Dual mechanism inhibitors for the treatment of disease

20210355163

2021-11-18

COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING

20200131171

2020-04-30

Dual mechanism inhibitors for the treatment of disease

20200055895

2020-02-20

COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING

20200002324

2020-01-02

Dual mechanism inhibitors for the treatment of disease

20180134748

2018-05-17

Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging

20180072678

2018-03-15

Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof

#10

20170298075

2017-10-19

Tetrahydroisoquinoline derived PRMT5-inhibitors

#11

20170267646

2017-09-21

Preparation method for revaprazan hydrochloride

#12

20160083423

2016-03-24

Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof

#13

20150284404

2015-10-08

Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors

#14

20150274713

2015-10-01

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#15

20140378506

2014-12-25

Compositions and methods for treatment

#16

20140371265

2014-12-18

Compositions and methods for treatment

#17

20140243524

2014-08-28

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#18

20140161872

2014-06-12

Compositions and methods for treatment

#19

20140141062

2014-05-22

Compositions and methods for treatment

#20

20130158015

2013-06-20

Dual mechanism inhibitors for the treatment of disease

#21

20130005965

2013-01-03

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#22

20120232019

2012-09-13

Compositions and methods for treatment of eye disorders

#23

20120135984

2012-05-31

DUAL-ACTION INHBITORS AND METHODS OF USING SAME

#24

20110281869

2011-11-17

TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS

#25

20110165229

2011-07-07

Compositions and methods for treatment

#26

20110165228

2011-07-07

Compositions and methods for treatment

#27

20100280028

2010-11-04

CXCR3 receptor antagonists

#28

20100280011

2010-11-04

Dual mechanism inhibitors for the treatment of disease

#29

20100092542

2010-04-15

Compositions and methods for treatment of eye disorders

#30

20100092541

2010-04-15

COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS

#31

20090253906

2009-10-08

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#32

20090054401

2009-02-26

Substituted bicyclic derivatives and use thereof

#33

20090048443

2009-02-19

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#34

20060281739

2006-12-14

Compositions and methods for treatment of eye disorders

#35

20060063766

2006-03-23

Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin

#36

20060052378

2006-03-09

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#37

15166964

2017-05-23

Use of isoquinoline derivatives for diabetic wound healing